In addition to the Managers, RTV has assembled an exceptional Advisory Board to assist in reviewing new investment opportunities and offering advice and counsel.

The General Partners look to each individual Advisory Board Member to provide timely and accurate recommendations and information. There are five primary functions targeted for the Advisory Board Members:

  • Identifying industry segments to be investigated
  • Reviewing selected business plans or executive summaries for due diligence purposes
  • Meeting with selected entrepreneurs to review the markets and technology
  • Providing other sources of due diligence
  • Assisting in deal monitoring, on-going market relationships and exit strategies

The members of the Advisory Board are as follows:

Bruce J. Boehm

Bruce is an independent venture capitalist, an advisor to several specialty venture capital funds, and an adjunct lecturer at the Kenan Flagler School of Business at UNC, Chapel Hill. From 1992 to 1996 he created and directed the Masters of Engineering Management Program at the University of Canterbury in Christchurch, New Zealand. Prior to 1992 he was a General Partner of U. S. Venture Partners in Menlo Park, California, with responsibility for a portfolio of approximately 20 health-care and technology investments. Prior to 1982 he was employed by a number of Silicon Valley and Route 128 companies as an engineer and project manager. Bruce received a BS from MIT, and an MS and MBA from Stanford University. During his career he has been a director of more than 25 publicly and privately held companies.


Kip Frey

Kip Frey is currently the Technology Venture Partner at Intersouth Partners and a Professor of the Practice in Entrepreneurial Management & Law at Duke University with joint appointments from the Fuqua School of Business and Duke Law School. Until June 2001, he was Vice President and General Manager of Dynamic Commerce Applications for Siebel Systems, Inc. (formerly OpenSite Technologies, Inc., an Intersouth portfolio company). Prior to that he served as President and Chief Executive Officer of OpenSite, which Siebel acquired in May of 2000.

Over the past five years, Kip has been the architect of three of the Triangle's most notable entrepreneurial deals, together generating more than $1 billion of investor returns. In 1995, Kip negotiated and closed the sale of Ventana Communications Group to the Thomson Corporation for an undisclosed sum. He next became President of Accipiter, Inc. and in 1998 sold the company to CMGI, Inc., structuring the transaction so that the ultimate value of the deal approached $500 million. Later in 1998, Kip moved to OpenSite, and in twenty months there increased its value from $6 million to the acquisition price of $550 million. In 1999, Digital South Magazine named him the Southeast's top CEO. Kip is currently the Chairman of the Council for Entrepreneurial Development (2001-2002).

Kip is an Adjunct Professor at Duke's Sanford Institute for Public Policy Studies and at Duke Law School, where he teaches courses in entrepreneurship and intellectual property. He is a member of the Board of Directors of the Raleigh Chamber of Commerce, the Council for Entrepreneurial Development, Duke Law School's Board of Visitors, and several local civic and charitable organizations. Kip is a Phi Beta Kappa graduate of the University of Southern California Film School and of Duke Law School.


John A. Irick

John has more than 25 years of business experience in the bioscience industry. He is currently Senior Vice President of Corporate and Business Development for Biolex, Inc. Prior to that he was Executive Vice President and Director of MERIX Bioscience, Inc., a venture-backed immunotherapy company. As co-founder of MERIX, he served as Chief Executive Officer during the organization and start-up of the company. Previously, John was President, Chief Executive Officer and Director of Apex Bioscience, Inc., a private, development-stage biotherapeutics company. Prior to being recruited to Apex, he was Vice President and Principal in The Shaw Group, a private life science incubator holding company, and concurrently served as Vice President, Commercial Development and Director of HemaGen/PFC, a private biopharmaceutical company. John spent 14 years at Baxter Healthcare Corporation in various management positions including Vice President in the Blood Therapy Group, Managing Director of Baxter's Spanish subsidiary, and Vice President of Business Operations at Baxter's Hyland Therapeutics Division. He is Chairman and President of the North Carolina Biosciences Organization (NCBIO) and a Director of the North Carolina Biotechnology Center. He is a former member of the Emerging Companies Section Governing Body and the Board of Directors of the Biotechnology Industry Organization (BIO) and was appointed by Governor Hunt as the pharmaceutical/biotechnology industry representative to the North Carolina Alliance for Competitive Technologies board. John earned an A.B. in mathematical economics from Brown University and an M.B.A. in marketing and finance from the University of Chicago.


Brent Keating

Brent has been involved in the knowledge based industries sector for over 17 years. In his current role he is responsible for managing and developing RBC Centura's Knowledge Based Industries (KBI) business throughout the South Eastern United States. This includes managing and developing relationships with public and private technology companies as well as early stage venture backed technology companies.

Through his work with technology companies, he has developed a good insight into the needs and issues facing this sector. The experience gained has enabled Brent to advise clients on matters of financial structuring, acquisitions, and international trade. Over the years Brent has been very involved with the industry, participating in mentoring groups for early stage companies and serving as a board member for several technology associations.


Dwight H. Sawin III

Dwight is presently a private investor and consultant to various high technology companies. He served as CEO of Millidyne, Inc. from 1988 to 1995 as the company installed wireless communications systems worldwide. Prior to that position Dwight served as Vice President for engineering and operations for Millidyne, Millicom International Cellular, and at the Foxboro Company. While at Millicom he was a member of the founding team of Vodafone/Airtouch PLC. He serves, and has served, as a director for several privately held companies in the technology and internet arenas, including TaskPoint.com, Electrifier, LIPSinc and SciQuest.com. Dwight earned his Ph.D., MSEE, and BSEE degrees from the University of Idaho.


Daniel J. Shea

Dan is a retired venture capitalist. He is a member of several organized groups of investment angels including Charlotte Angel Partners, TriState Investment Group in Chapel Hill, New Vantage Partners in Washington, DC and Batterson Venture Partners in Chicago. Dan was formerly a partner with Kitty Hawk Capital, a Charlotte, NC based venture capital firm. Before that, Dan spent ten years with Scientific Advances, the venture capital arm of Battelle Memorial Institute, a large independent contract research organization. There, Dan both led and participated in technology company investments in Silicon Valley, Boston's Route 128 and around the country. Prior to entering the venture capital industry, Dan served as a consultant to venture capital firms and technology-based companies in the San Francisco Bay area. Dan is a member of the Entrepreneurial Development Board of the State of North Carolina and a former director of the Council for Entrepreneurial Development and the First Coast Venture Capital Group. He has been a director of numerous venture capital-backed companies and is a graduate of Brooklyn Polytechnic Institute, B.Chem.E. and Harvard Business School, MBA.


Stephen Walsh Ph.D.

Steve co-founded BOPS Inc. in 1997 and served as the first President of the company. During the start-up phase, he was responsible for recruiting the initial management and technical teams, managing start-up operations, business planning, and initial fund raising activities. Steve worked closely with the initial management team to further develop and refine the BOPSŪ Business Plan and to assist in fund raising and customer negotiations. Steve has over 17 years of industrial experience in both technical and marketing positions. He holds a BSEE from Rutgers College of Engineering, an MS and Ph.D. degrees in Electrical Engineering from Duke University.


Catalysta Partners

Catalysta Partners is a venture management firm focused on bringing technologies from idea to market. Since 1998, the firm has been involved with over 20 clients and portfolio companies, providing key guidance regarding the sales, marketing, and business development process, as well as operating in strategic management roles inside companies. Through Catalysta's venture arm, Catalysta Ventures, the firm plays a role in co-founding companies by providing essential leadership, management assistance, and financial investment early in a company's life. As a team, Catalysta's partners bring over 100 years of entrepreneurial and product commercialization experience in the Information Technology and Life Sciences arenas. Key individuals within Catalysta Partners working with RTV are as follows:


John Crumpler

John has over 20 years experience in birthing, building and managing top tier, fast paced organizations and start-up ventures in a variety of fields, including high tech, government, politics, and charitable foundations. As the founder and top executive of E-Comm, Inc., a software integration firm in the Research Triangle, John's leadership produced consistent annual triple digit revenue growth rates and profits exceeding 35%. In 1996, E-Comm was acquired by XcelleNet, Inc. to become XcelleNet Services, where John was President until 1998, when XcelleNet was acquired by Sterling Commerce for $240 million in cash and stock. John holds a BA from Harvard University.


Michael Jongkind

Michael has been focused on technology business development throughout his career. Recently, he was Vice President of Business Development at SND, a software integration firm focused on the needs of the pharmaceutical industry. At SND, he was responsible for business partnerships and for the search process that led to SND's eventual sale to E-Presence (formerly known as Banyan Systems) for $32 million in cash and stock. Prior to SND, Michael was a co-founder and Vice President of E-Comm, where he focused on business development and revenue generation from the company's inception in 1993 until its acquisition by XcelleNet in 1997. Earlier, Michael was involved in key sales, marketing, and business development roles with Bellsouth/RAM Mobile Data and Nynex. Michael holds a BA in Telecommunications from Indiana University.


Mark McCurry

Mark is an experienced professional in sales and marketing of high technology products. Mark was recently Senior Vice President of Worldwide Sales for Per-Se Technologies, where he successfully rolled up three separate software organizations acquired by Medaphis Corporation. Total revenues for Per-Se Technologies were $300 million in 1998. Mark also led U.S. sales operations for GEAC Smartstream, formerly Dun & Bradstreet Software, where he was responsible for $110 million in annual revenues and assisted in the successful sale of Dun & Bradstreet Software to GEAC Smartstream. Pioneering early sales in the emerging wireless mobile data market, Mark built a sales organization for a $400 million joint venture between BellSouth and Ram Broadcasting Corporation. Mark is a former member of the Bellsouth Wireless Steering Committee. Mark holds a BA degree in history from North Carolina A&T State University.


Clay Thorp

Prior to Catalysta, Clay was the Director of Corporate Development at Novalon Pharmaceutical Corporation, a biotechnology company in the Research Triangle. Clay led business development, planning and capital development efforts at the company from Novalon's inception in 1996 until its sale to Karo Bio AB of Stockholm, Sweden in May 2000 in a public stock transaction valued at $106.7 million. Prior to Novalon, Clay was co-founder and President of Xanthon, Inc., a genomics company focused on the analysis of gene expression using proprietary electrochemistry, where he was responsible for developing the company's business plan, securing the original venture investors, and structuring the company's relationships with the University of North Carolina at Chapel Hill and potential licensees of the company's technologies. Clay holds a Master of Public Policy from Harvard University and a BA from the University of North Carolina at Chapel Hill in Mathematics and Art History.